Literature DB >> 33320187

Proton Pump Inhibitors and Incident Clostridioides difficile Infection: Beyond Controversy, Pragmatic Approaches Are Needed.

Javier A Villafuerte-Gálvez1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33320187      PMCID: PMC8204780          DOI: 10.1093/cid/ciaa1856

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  17 in total

1.  Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP): Randomized Double-Blind Exploratory Study.

Authors:  Shane P Selvanderan; Matthew J Summers; Mark E Finnis; Mark P Plummer; Yasmine Ali Abdelhamid; Michael B Anderson; Marianne J Chapman; Christopher K Rayner; Adam M Deane
Journal:  Crit Care Med       Date:  2016-10       Impact factor: 7.598

2.  Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Authors:  Paul Moayyedi; John W Eikelboom; Jackie Bosch; Stuart J Connolly; Leanne Dyal; Olga Shestakovska; Darryl Leong; Sonia S Anand; Stefan Störk; Kelley R H Branch; Deepak L Bhatt; Peter B Verhamme; Martin O'Donnell; Aldo P Maggioni; Eva M Lonn; Leopoldo S Piegas; Georg Ertl; Matyas Keltai; Nancy Cook Bruns; Eva Muehlhofer; Gilles R Dagenais; Jae-Hyung Kim; Masatsugu Hori; P Gabriel Steg; Robert G Hart; Rafael Diaz; Marco Alings; Petr Widimsky; Alvaro Avezum; Jeffrey Probstfield; Jun Zhu; Yan Liang; Patricio Lopez-Jaramillo; Ajay K Kakkar; Alexander N Parkhomenko; Lars Ryden; Nana Pogosova; Antonio L Dans; Fernando Lanas; Patrick J Commerford; Christian Torp-Pedersen; Tomek J Guzik; Dragos Vinereanu; Andrew M Tonkin; Basil S Lewis; Camilo Felix; Khalid Yusoff; Kaj P Metsarinne; Keith A A Fox; Salim Yusuf
Journal:  Gastroenterology       Date:  2019-05-29       Impact factor: 22.682

Review 3.  Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms.

Authors:  Jeffrey H William; John Danziger
Journal:  World J Nephrol       Date:  2016-03-06

4.  Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.

Authors:  Waleed Alhazzani; Gordon Guyatt; Mohammed Alshahrani; Adam M Deane; John C Marshall; Richard Hall; John Muscedere; Shane W English; François Lauzier; Lehana Thabane; Yaseen M Arabi; Tim Karachi; Bram Rochwerg; Simon Finfer; Nick Daneman; Fayez Alshamsi; Nicole Zytaruk; Diane Heel-Ansdell; Deborah Cook
Journal:  Crit Care Med       Date:  2017-07       Impact factor: 7.598

5.  Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU.

Authors:  Mette Krag; Søren Marker; Anders Perner; Jørn Wetterslev; Matt P Wise; Joerg C Schefold; Frederik Keus; Anne B Guttormsen; Stepani Bendel; Mark Borthwick; Theis Lange; Bodil S Rasmussen; Martin Siegemund; Helle Bundgaard; Thomas Elkmann; Jacob V Jensen; Rune D Nielsen; Lisbeth Liboriussen; Morten H Bestle; Jeanie M Elkjær; Dorte F Palmqvist; Minna Bäcklund; Jon H Laake; Per M Bådstøløkken; Juha Grönlund; Olena Breum; Akil Walli; Robert Winding; Susanne Iversen; Inge-Lise Jarnvig; Jonathan O White; Björn Brand; Martin B Madsen; Lars Quist; Klaus J Thornberg; Anders Møller; Jørgen Wiis; Anders Granholm; Carl T Anthon; Tine S Meyhoff; Peter B Hjortrup; Søren R Aagaard; Jo B Andreasen; Christina A Sørensen; Pernille Haure; Jacob Hauge; Alexa Hollinger; Jonas Scheuzger; Daniel Tuchscherer; Thierry Vuilliomenet; Jukka Takala; Stephan M Jakob; Marianne L Vang; Kim B Pælestik; Karen L D Andersen; Iwan C C van der Horst; Willem Dieperink; Jesper Fjølner; Cilia K W Kjer; Christine Sølling; Christoffer G Sølling; Johanna Karttunen; Matt P G Morgan; Brit Sjøbø; Janus Engstrøm; Birgit Agerholm-Larsen; Morten H Møller
Journal:  N Engl J Med       Date:  2018-10-24       Impact factor: 91.245

6.  Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea.

Authors:  R Cunningham; B Dale; B Undy; N Gaunt
Journal:  J Hosp Infect       Date:  2003-07       Impact factor: 3.926

7.  Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.

Authors:  Vanessa Arriola; Jessica Tischendorf; Jackson Musuuza; Anna Barker; Jeffrey W Rozelle; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2016-09-28       Impact factor: 3.254

8.  Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.

Authors:  Willy Gomm; Klaus von Holt; Friederike Thomé; Karl Broich; Wolfgang Maier; Anne Fink; Gabriele Doblhammer; Britta Haenisch
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

9.  Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.

Authors:  T S G Sehested; T A Gerds; E L Fosbøl; P W Hansen; M G Charlot; N Carlson; M A Hlatky; C Torp-Pedersen; G H Gislason
Journal:  J Intern Med       Date:  2017-11-07       Impact factor: 8.989

10.  Proton pump inhibitors affect the gut microbiome.

Authors:  Floris Imhann; Marc Jan Bonder; Arnau Vich Vila; Jingyuan Fu; Zlatan Mujagic; Lisa Vork; Ettje F Tigchelaar; Soesma A Jankipersadsing; Maria Carmen Cenit; Hermie J M Harmsen; Gerard Dijkstra; Lude Franke; Ramnik J Xavier; Daisy Jonkers; Cisca Wijmenga; Rinse K Weersma; Alexandra Zhernakova
Journal:  Gut       Date:  2015-12-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.